Treacherous apoptosis—Cancer cells sacrifice themselves at the altar of heterogeneity
Renumathy Dhanasekaran – 25 February 2022
Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitis
Surain B. Roberts, Gideon M. Hirschfield, Lawrence J. Worobetz, Catherine Vincent, Jennifer A. Flemming, Angela Cheung, Karim Qumosani, Mark Swain, Dusanka Grbic, Hin Hin Ko, Kevork Peltekian, Nazia Selzner, Lusine Abrahamyan, Bishoi Aziz, Ellina Lytvyak, Kattleya Tirona, Aliya F. Gulamhusein, Harry L. A. Janssen, Aldo J. Montano‐Loza, Andrew L. Mason, Bettina E. Hansen, the Canadian Network for Autoimmune Liver Disease (CaNAL) – 25 February 2022
Letter to the editor: Using angiotensin‐converting enzyme inhibitors to prevent liver‐related events in NAFLD—Revisiting the renin–angiotensin–aldosterone system pathways
Manas Kumar Panigrahi, Prajna Anirvan – 25 February 2022
Dual roles of B lymphocytes in mouse models of diet‐induced nonalcoholic fatty liver disease
Martin Karl, Solveig Hasselwander, Yawen Zhou, Gisela Reifenberg, Yong Ook Kim, Kyoung‐Sook Park, Dirk A. Ridder, Xiaoyu Wang, Eric Seidel, Nadine Hövelmeyer, Beate K. Straub, Huige Li, Detlef Schuppan, Ning Xia – 25 February 2022
Reply
Xinrong Zhang, Grace Lai‐Hung Wong, Terry Cheuk‐Fung Yip, Vincent Wai‐Sun Wong – 25 February 2022
Reply
Anna Linda Zignego, Laura Gragnani, Loreta A. Kondili – 25 February 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
Ibon Martínez‐Arranz, Chiara Bruzzone, Mazen Noureddin, Ruben Gil‐Redondo, Itziar Mincholé, Maider Bizkarguenaga, Enara Arretxe, Marta Iruarrizaga‐Lejarreta, David Fernández‐Ramos, Fernando Lopitz‐Otsoa, Rebeca Mayo, Nieves Embade, Elizabeth Newberry, Bettina Mittendorf, Laura Izquierdo‐Sánchez, Vaclav Smid, Jorge Arnold, Paula Iruzubieta, Ylenia Pérez Castaño, Marcin Krawczyk, Urko M. Marigorta, Martine C.
Seeking editor for Clinical Liver Disease
23 February 2022
Reply
Ji Zhang, Tingting Zhao, Lai Wei, Yuzhang Wu – 23 February 2022
Development of a Robotic Shear Wave Elastography System for Noninvasive Staging of Liver Disease in Murine Models
Tomasz J. Czernuszewicz, Adam M. Aji, Christopher J. Moore, Stephanie A. Montgomery, Brian Velasco, Gabriela Torres, Keerthi S. Anand, Kennita A. Johnson, Allison M. Deal, Dženan Zukić, Matthew McCormick, Bernd Schnabl, Caterina M. Gallippi, Paul A. Dayton, Ryan C. Gessner – 23 February 2022 – Shear wave elastography (SWE) is an ultrasound‐based stiffness quantification technology that is used for noninvasive liver fibrosis assessment.